
Cornea and External Disease
Phase 3 trial of cenegermin-bkbj for PCED enrolls first US patient
The first patient in the United States has been dosed in a Phase 3 clinical trial evaluating cenegermin-bkbj ophthalmic solution for the...
Cornea specialists identify key clinical signs linked to microbial keratitis subtypes
United States cornea specialists identified a limited set of clinical features they believe reliably distinguish microbial keratitis (MK) organism groups, according to...
Preventing complications of superficial keratectomy
The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or...
Latest Cornea and External Disease Videos
UV Light-emitting Contact Lens Device for Corneal Collagen Crosslinking Stabilizes Corneas with Keratoconus
An ultraviolet (UV) light-emitting contact lens device for corneal collagen crosslinking stabilizes and flattens corneas with keratoconus, according to a poster presented at the American Society of Cataract and Refractive...
Needling after Subconjunctival Gelatin Stent Placement May Not Be Needed
No significant difference in success rate or in rate of subsequent surgery was found in patients who underwent subconjunctival gelatin stent placement followed by needling or placement on antiglaucoma medications...
Autologous Limbal Stem Cell Transplant Has Higher Success Rate than Allogenic
A comparison of different limbal stem cell transplant (LSCT) procedures suggests that autologous LSCT may have a higher success rate and lower complication rate than other LSCT types, according to...
Long-term Visual Outcomes in Children with NF1-associated Optic Pathway Gliomas
In patients with Neurofibromatosis type 1 (NF1), optic pathway gliomas (OPGs) are common and can cause significant visual morbidity. In this retrospective observational case series, the visual acuity (VA) per...
Antibiotic Resistance Trends Among Ocular Pathogens
A new study in JAMA Ophthalmology sought to investigate antibiotic resistance profiles and trends in ocular pathogens. In this cross-sectional study of longitudinal data from the Antibiotic Resistance Monitoring in...
Positive Phase 2a Study Results Announced for Thyroid Eye Disease Treatment
A thyroid eye disease treatment candidate showed a 65% improvement in IgG levels in a phase 2a proof-of-concept study, according to a press release by Immunovant, Inc. IMVT-1401, a novel...